|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$305,473
|
$30,547
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$30,758
|
Barr, Frederic
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,857,052
|
$742,855
|
Custer, Mary
|
CCR (NCI)
|
|
Biochemical Basis of T Cell Activation
|
ZIA BC 010304
|
$1,382,902
|
$691,451
|
Samelson, Lawrence
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$379,286
|
$18,964
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$3,493,116
|
$174,656
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133 04180
|
$145,295
|
$2,906
|
Linet, Martha
|
DCEG (NCI)
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
3P30CA021765-39S1
|
$134,625
|
$4,039
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
3P30CA021765-39S2
|
$58,898
|
$1,767
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
5P30CA021765-39
|
$6,063,271
|
$181,898
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer following radiotherapy for benign gynecologic disorders
|
ZIA CP010131 04021
|
$30,751
|
$1,845
|
Little, Mark
|
DCEG (NCI)
|
|
Cancer Risk in Solid Organ Transplant Recipients
|
ZIA CP010150 10362
|
$146,079
|
$7,304
|
Engels, Eric
|
DCEG (NCI)
|
|
CCR Genomics Core
|
ZIC BC 011623
|
$665,279
|
$66,528
|
Conner, Elizabeth
|
CCR (NCI)
|
|
CCSS circulatory disease
|
ZIA CP010132 10623
|
$97,109
|
$19,422
|
Little, Mark
|
DCEG (NCI)
|
|
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
|
5R01CA213138-02
|
$395,738
|
$130,594
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Childhood Cancer Survivor Study
|
3U24CA055727-24S1
|
$120,439
|
$12,044
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-24
|
$4,218,764
|
$421,876
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Childhood cancer survivor study (CCSS)
|
ZIA CP010131 04033
|
$11,662
|
$1,749
|
Morton, Lindsay
|
DCEG (NCI)
|
|
Childrens Oncology Group Statistics and Data Center
|
5U10CA180899-05
|
$7,738,106
|
$773,811
|
DEVIDAS, MEENAKSHI
|
UNIVERSITY OF FLORIDA
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-11A1
|
$2,500,000
|
$900,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors
|
5R01CA204258-02
|
$626,296
|
$87,681
|
NICHOLS, HAZEL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
$90,276
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
$834,152
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S1
|
$142,498
|
$2,850
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S2
|
$200,000
|
$4,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
$52,912
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Defining the Biological and Mechanistic Implications of XPO1 Mutations in Hematologic Malignancies
|
1K08CA230319-01
|
$244,470
|
$61,118
|
TAYLOR, JUSTIN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Demonstrating the feasibility of CCG-257081 as a preventive therapy to inhibit bleomycin-induced lung fibrosis in mice
|
1R43CA235823-01
|
$300,000
|
$300,000
|
VARNUM, MEGAN
|
FIBROSIX, LLC
|
|
Dermatology Consultation Service
|
ZID BC 011317
|
$9,978
|
$2,993
|
Cowen, Edward
|
CCR (NCI)
|
|
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
|
ZID BC 011792
|
$244,173
|
$12,209
|
Pack, Svetlana
|
CCR (NCI)
|
|
Development of fully-human anti-CD30 chimeric antigen receptors
|
ZIA BC 011660
|
$95,505
|
$76,404
|
Kochenderfer, James
|
CCR (NCI)
|
|
Development of Novel Therapies for HIV Infection
|
ZIA SC 006737
|
$49,491
|
$14,352
|
Yarchoan, Robert
|
CCR (NCI)
|
|
DNA repair
|
ZIA BC 010283
|
$1,309,141
|
$222,554
|
Nussenzweig, Andre
|
CCR (NCI)
|
|
EBV LMP1/LMP2A Proteins Promote Hodgkin-like Lymphomas in Humanized Mice
|
1R01CA232616-01
|
$381,507
|
$381,507
|
KENNEY, SHANNON
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation
|
5R01CA047006-31
|
$532,500
|
$266,250
|
ZHAO, BO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,978,942
|
$197,894
|
Gress, Ronald
|
CCR (NCI)
|
|
Familial case-control study of lymphoproliferative malignancies and auto-immune d
|
ZIA CP005803 00355
|
$13,239
|
$2,648
|
Goldin, Lynn
|
DCEG (NCI)
|
|
Follow-up studies from the NHL/LM GWAS
|
ZIA CP010136 10799
|
$47,640
|
$4,764
|
Berndt, Sonja
|
DCEG (NCI)
|
|
Genomics of multiple primary tumors
|
ZIA CP010131 10782
|
$30,751
|
$3,075
|
Morton, Lindsay
|
DCEG (NCI)
|
|
Hematopathology Diagnosis
|
ZIA BC 011070
|
$641,445
|
$192,433
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Hematopathology Fellowship
|
ZIE BC 011241
|
$400,903
|
$100,226
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Hemopoietic malignancies among persons exposed to low and moderate ionizing radia
|
ZIA CP010131 10715
|
$61,503
|
$6,150
|
Little, Mark
|
DCEG (NCI)
|
|
HIV and Cancer
|
ZIA CP010150 10071
|
$63,128
|
$9,469
|
Engels, Eric
|
DCEG (NCI)
|
|
Hodgkin's families
|
ZIA CP004410 08167
|
$69,137
|
$65,680
|
Goldin, Lynn
|
DCEG (NCI)
|
|
Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients
|
5R01CA206019-03
|
$802,716
|
$802,716
|
COZEN, WENDY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
|
ZIA BC 010598
|
$785,837
|
$39,292
|
Schlom, Jeffrey
|
CCR (NCI)
|
|
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
|
ZIA SC 004002
|
$1,096,433
|
$219,287
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$364,078
|
$72,816
|
Rose, Jeremy
|
CCR (NCI)
|
|
Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules
|
ZIA BC 011215
|
$263,049
|
$26,305
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
|
ZIA BC 008753
|
$1,671,202
|
$250,680
|
Pastan, Ira
|
CCR (NCI)
|
Total relevant funding to Hodgkins disease for this search: $13,282,652
|